Haohua Chemical Science & Technology Corp., Ltd. (SHA:600378)
China · Delayed Price · Currency is CNY 36.40
+0.73 (2.05%)
Apr 30, 2026, 3:00 PM CST
SHA:600378 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 17,763 | 16,689 | 13,531 | 14,042 | 8,698 | 6,944 |
Other Revenue | - | - | 435.35 | 480.7 | 369.92 | 480.54 |
| 17,763 | 16,689 | 13,966 | 14,523 | 9,068 | 7,424 | |
Revenue Growth (YoY) | 24.41% | 19.50% | -3.83% | 60.17% | 22.13% | 36.92% |
Cost of Revenue | 13,251 | 12,475 | 11,103 | 11,308 | 6,895 | 5,444 |
Gross Profit | 4,512 | 4,214 | 2,863 | 3,215 | 2,173 | 1,980 |
Selling, General & Admin | 1,538 | 1,513 | 1,345 | 1,381 | 728.23 | 736.11 |
Research & Development | 949.43 | 966.09 | 927.37 | 982.46 | 641.88 | 542.72 |
Other Operating Expenses | -104.44 | -136.4 | -198.11 | -189.07 | -237.05 | -212.44 |
Operating Expenses | 2,383 | 2,343 | 2,111 | 2,188 | 1,170 | 1,079 |
Operating Income | 2,129 | 1,871 | 752.65 | 1,027 | 1,003 | 900.91 |
Interest Expense | - | - | -98.44 | -100.89 | -37.39 | -24.69 |
Interest & Investment Income | 335.39 | 350.9 | 358.73 | 335.91 | 71.49 | 44.51 |
Currency Exchange Gain (Loss) | - | - | 20.57 | 16.71 | 12.39 | -2.26 |
Other Non Operating Income (Expenses) | -75.44 | -49.16 | 206.27 | 40.38 | 48.99 | 77.28 |
EBT Excluding Unusual Items | 2,389 | 2,173 | 1,240 | 1,319 | 1,098 | 995.74 |
Gain (Loss) on Sale of Investments | -5.1 | -4.52 | 1.93 | 3.84 | -0.12 | 0.18 |
Gain (Loss) on Sale of Assets | 14.96 | 15.51 | 56.25 | 50.81 | 254.13 | 10.59 |
Asset Writedown | -231.17 | -245.72 | -7.7 | -27.61 | -10.12 | -5.56 |
Other Unusual Items | - | - | -102.46 | 62 | -6.82 | -2.87 |
Pretax Income | 2,168 | 1,938 | 1,188 | 1,408 | 1,335 | 998.09 |
Income Tax Expense | 356.86 | 296.03 | 82.84 | 219.77 | 165.29 | 94.96 |
Earnings From Continuing Operations | 1,811 | 1,642 | 1,105 | 1,188 | 1,170 | 903.14 |
Minority Interest in Earnings | -242.92 | -197.6 | -51.17 | -5.21 | -5.03 | -11.68 |
Net Income | 1,568 | 1,444 | 1,054 | 1,183 | 1,165 | 891.46 |
Net Income to Common | 1,568 | 1,444 | 1,054 | 1,183 | 1,165 | 891.46 |
Net Income Growth | 46.33% | 37.07% | -10.94% | 1.57% | 30.68% | 37.61% |
Shares Outstanding (Basic) | 1,290 | 1,290 | 1,106 | 1,109 | 905 | 902 |
Shares Outstanding (Diluted) | 1,290 | 1,290 | 1,106 | 1,109 | 905 | 902 |
Shares Change (YoY) | 11.92% | 16.67% | -0.26% | 22.50% | 0.30% | 0.09% |
EPS (Basic) | 1.22 | 1.12 | 0.95 | 1.07 | 1.29 | 0.99 |
EPS (Diluted) | 1.22 | 1.12 | 0.95 | 1.07 | 1.29 | 0.99 |
EPS Growth | 30.74% | 17.49% | -10.71% | -17.08% | 30.29% | 37.49% |
Free Cash Flow | 30.96 | 401.98 | -1,399 | -916.39 | -622.73 | 299.64 |
Free Cash Flow Per Share | 0.02 | 0.31 | -1.27 | -0.83 | -0.69 | 0.33 |
Dividend Per Share | - | - | 0.286 | 0.346 | 0.640 | 0.291 |
Dividend Growth | - | - | -17.34% | -45.94% | 119.86% | 17.85% |
Gross Margin | 25.40% | 25.25% | 20.50% | 22.14% | 23.96% | 26.67% |
Operating Margin | 11.98% | 11.21% | 5.39% | 7.07% | 11.06% | 12.13% |
Profit Margin | 8.83% | 8.65% | 7.54% | 8.15% | 12.85% | 12.01% |
Free Cash Flow Margin | 0.17% | 2.41% | -10.02% | -6.31% | -6.87% | 4.04% |
EBITDA | 3,440 | 3,125 | 1,778 | 1,978 | 1,409 | 1,228 |
EBITDA Margin | 19.37% | 18.73% | 12.73% | 13.62% | 15.54% | 16.54% |
D&A For EBITDA | 1,312 | 1,254 | 1,025 | 951.05 | 406.63 | 326.74 |
EBIT | 2,129 | 1,871 | 752.65 | 1,027 | 1,003 | 900.91 |
EBIT Margin | 11.98% | 11.21% | 5.39% | 7.07% | 11.06% | 12.13% |
Effective Tax Rate | 16.46% | 15.27% | 6.97% | 15.61% | 12.38% | 9.51% |
Revenue as Reported | - | - | 13,966 | 14,523 | 9,068 | 7,424 |
Advertising Expenses | - | - | 4.35 | 7.06 | 0.92 | 0.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.